Phase 1 Study of C.001 in Retinal Degeneration

Clinical trial NCT07594236 · RECRUITING

Trial details

NCT number: NCT07594236
Sponsor: Cellio Therapeutics Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Geographic Atrophy Stargardt Disease RPE-mediated Maculopathy Age Related Macular Degeneration

Start date: 2026-04-07
Primary completion: 2028-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.